BackAdaptimmune Therapeutics Plc Overview

Adaptimmune Therapeutics Plc Other Current Assets

Track Adaptimmune Therapeutics Plc's other current assets ($12M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$11.75M
↓ 22.79% YoYΔ $-3.47M vs prior year quarter

Peer average

Loading

Adaptimmune Therapeutics Plc Other Current Assets History

Loading

Adaptimmune Therapeutics Plc vs. peers: Other Current Assets Comparison

Loading

Adaptimmune Therapeutics Plc Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Adaptimmune Therapeutics Plc (ADAP) FAQ

As of the most recent data (June 2025), ADAP shows a other current assets of $12M. That compares with $15M in the prior-year period — down 22.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADAP's other current assets is now $12M (was $15M) — a 22.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Adaptimmune Therapeutics Plc is outperforming or lagging.

Tracking ADAP's other current assets over time shows whether Adaptimmune Therapeutics Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $12M That compares with $15M in the prior-year period — down 22.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Adaptimmune Therapeutics Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $12M) with ownership activity and broader fundamentals.

Adaptimmune Therapeutics Plc's other current assets is $12M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.